Literature DB >> 19464125

Behavioral economic analysis of opioid consumption in heroin-dependent individuals: effects of alternative reinforcer magnitude and post-session drug supply.

Mark K Greenwald1, Caren L Steinmiller.   

Abstract

This study investigated the extent to which hydromorphone (HYD) choice and behavioral economic demand were influenced by HYD unit price (UP), alternative money reinforcement magnitude and post-session HYD supply. Heroin-dependent research volunteers (n=13) stabilized on buprenorphine 8 mg/day first sampled two HYD doses (12 and 24 mg IM, labeled Drug A [session 1] and Drug B [session 2]). In each of the final six sessions, volunteers were given access to a 12-trial choice progressive ratio (PR) task and could earn a HYD unit dose (2 mg, fixed) or money ($2 or $4, varied across sessions), administered immediately after the work session. Before the PR task, volunteers were told which HYD supplemental dose (none, Drug A or B) would be available 3h after receiving the PR-contingent dose. PR-contingent HYD choice significantly decreased when $4 relative to $2 was concurrently available. Information about the post-session HYD supplement moderated this effect: when subjects were told a supplemental dose was available, HYD-seeking behavior decreased when the money alternative was smaller ($2), but this information did not further attenuate HYD choice, which was already low, when the money alternative was higher ($4). HYD demand elasticity was only increased by the $4 relative to $2 alternative without the HYD supplement. In summary, opioid-seeking behavior is influenced by the availability of concurrent non-drug and drug alternatives. These findings show that drug availability and non-drug alternatives interact to modulate drug-seeking behavior.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464125      PMCID: PMC2724970          DOI: 10.1016/j.drugalcdep.2009.04.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  57 in total

1.  Behavioral economics of drug self-administration. II. A unit-price analysis of cigarette smoking.

Authors:  W K Bickel; R J DeGrandpre; J R Hughes; S T Higgins
Journal:  J Exp Anal Behav       Date:  1991-03       Impact factor: 2.468

2.  Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.

Authors:  H M Rhoades; D Creson; R Elk; J Schmitz; J Grabowski
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

3.  Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.

Authors:  David A Gorelick; Yu Kyeong Kim; Badreddine Bencherif; Susan J Boyd; Richard Nelson; Marc Copersino; Christopher J Endres; Robert F Dannals; J James Frost
Journal:  Biol Psychiatry       Date:  2005-06-15       Impact factor: 13.382

4.  Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.

Authors:  J K Zubieta; D A Gorelick; R Stauffer; H T Ravert; R F Dannals; J J Frost
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

5.  Survey assessment of methadone treatment services as reinforcers.

Authors:  M A Chutuape; K Silverman; M L Stitzer
Journal:  Am J Drug Alcohol Abuse       Date:  1998-02       Impact factor: 3.829

6.  Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance.

Authors:  K L Preston; A Umbricht; D H Epstein
Journal:  Arch Gen Psychiatry       Date:  2000-04

7.  Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.

Authors:  Patrick Gschwend; Jürgen Rehm; Richard Blättler; Thomas Steffen; André Seidenberg; Stephan Christen; Christoph Bürki; Felix Gutzwiller
Journal:  Eur Addict Res       Date:  2004       Impact factor: 3.015

8.  Computerized behavior therapy for opioid-dependent outpatients: a randomized controlled trial.

Authors:  Warren K Bickel; Lisa A Marsch; August R Buchhalter; Gary J Badger
Journal:  Exp Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.157

9.  Behavior therapy in drug abuse treatment: review and evaluation.

Authors:  M L Stitzer; G E Bigelow; M E McCaul
Journal:  NIDA Res Monogr       Date:  1985

10.  Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?

Authors:  Nancy M Petry; Jacqueline Tedford; Mark Austin; Charla Nich; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526

View more
  17 in total

1.  Effects of experimental Unemployment, Employment and Punishment analogs on opioid seeking and consumption in heroin-dependent volunteers.

Authors:  Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

2.  Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.

Authors:  Azmi F Nasser; Mark K Greenwald; Bradley Vince; Paul J Fudala; Philip Twumasi-Ankrah; Yongzhen Liu; J P Jones; Christian Heidbreder
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153

Review 3.  Unpredictability as a modulator of drug self-administration: Relevance for substance-use disorders.

Authors:  Sally L Huskinson
Journal:  Behav Processes       Date:  2020-06-08       Impact factor: 1.777

4.  Environmental enrichment and drug value: a behavioral economic analysis in male rats.

Authors:  Justin R Yates; Michael T Bardo; Joshua S Beckmann
Journal:  Addict Biol       Date:  2017-11-27       Impact factor: 4.280

5.  Heroin purchasing is income and price sensitive.

Authors:  Juliette Roddy; Caren L Steinmiller; Mark K Greenwald
Journal:  Psychol Addict Behav       Date:  2011-06

6.  Motivational assessment of non-treatment buprenorphine research participation in heroin dependent individuals.

Authors:  Gina Papke; Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2011-12-02       Impact factor: 4.492

7.  Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.

Authors:  Mark K Greenwald; Leslie H Lundahl; Caren L Steinmiller
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

8.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24

Review 9.  Clinical models of decision making in addiction.

Authors:  Mikhail N Koffarnus; Brent A Kaplan
Journal:  Pharmacol Biochem Behav       Date:  2017-08-26       Impact factor: 3.533

Review 10.  Medications development for opioid abuse.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.